Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Melatonin for the Treatment of Handicapped Children with Severe Sleep Disorder.
علاج الميلاتونين لمشاكل النوم لدى الأطفال .
Document Language
:
English
Abstract
:
Sleep disorders are common in children with mental retardation and neurological disorders. Melatonin is a recently developed natural compound that has been used successfully in sleep disorders. Our objective is to report our experience with melatonin for the treatment of circadian rhythm sleep disorder in handicapped children. An open trial of melatonin in a group of handicapped children with severe sleep disorder was conducted prospectively. The circadian rhythm sleep disorder was persistent for at least 6 months and failed to respond to at least 1 hypnotic drug. Therapeutic response was recorded according to: 1) The average number of hours asleep per 24 hours, 2) The average number of awakening per night, 3) The average number of nights with delayed sleep onset, and 4) The average number of nights with early morning arousals. Ten consecutive children (4 males and 6 females) with ages ranging between 1-11 years (mean 5.4) were included. Nine children had documented mental retardation, which was severe in 6 (67%). The majority of children had epilepsy and visual impairment (70%). All children were followed for 4-12 months (mean 7.5) following the initiation of a 3 mg bedtime melatonin. The majority (80%) had a dramatic response to melatonin. One child had a history of persistent nocturnal enuresis, which completely resolved after initiating melatonin therapy. No side effects were reported. To conclude, melatonin is a well tolerated, safe, and very effective drug for the treatment of severe circadian rhythm sleep disorder in handicapped children. It has minimal side effects and is relatively inexpensive. Wider use of this drug is recommended.
ISSN
:
0940-5429
Journal Name
:
Pediatric Neurology
Volume
:
3
Issue Number
:
23
Publishing Year
:
2000 AH
2000 AD
Article Type
:
Article
Added Date
:
Saturday, March 13, 2010
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
محمد جان
jan, Mohammed
Researcher
Doctorate
Files
File Name
Type
Description
25938.doc
doc
Back To Researches Page